Status:
COMPLETED
Platelet-Rich Plasma (PRP) Injection for the Treatment of Chronic Patellar Tendinopathy
Lead Sponsor:
University of Wisconsin, Madison
Conditions:
Chronic Patellar Tendinopathy
Chronic PT
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
The goal of this study is to find an effective treatment for chronic patellar tendinopathy (PT). Investigators will conduct a 32-week randomized controlled clinical trial to determine whether platelet...
Detailed Description
This study is a randomized, single-blinded controlled trial. Subjects, aged 18-65 with chronic patellar tendinopathy (PT), will be recruited through the University of Wisconsin (UW) Sports Medicine Cl...
Eligibility Criteria
Inclusion
- age18-65
- chronic (\>3months) patellar tendon pain;
- clinical exam findings consistent with PT;
- self-reported failure of supervised physical therapy;
- self-reported failure of at least 2 of the most common treatments (NSAIDs, relative rest, ice, bracing) for patellar tendinopathy.
Exclusion
- inability to comply with follow-up requirements of study,
- history of bleeding disorders, low-platelet counts, other hematologic conditions;
- knee pain due to another possible etiology(e.g., degenerative joint disease);
- current or recent use of anticoagulation or immunosuppressive therapy;
- known allergy to acetaminophen or Lidocaine;
- self-reported pregnancy;
- worker's compensation injury;
- pending litigation;
- concurrent opioid use for pain
Key Trial Info
Start Date :
January 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 29 2024
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT01843504
Start Date
January 1 2014
End Date
February 29 2024
Last Update
April 26 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Wisconsin Institute of Medical Research
Madison, Wisconsin, United States, 53705
2
UW Sports Medicine Clinic at Research Park
Madison, Wisconsin, United States, 53711